Ferdows Atiq

706 total citations
36 papers, 397 citations indexed

About

Ferdows Atiq is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Ferdows Atiq has authored 36 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Surgery. Recurrent topics in Ferdows Atiq's work include Platelet Disorders and Treatments (25 papers), Blood groups and transfusion (14 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (8 papers). Ferdows Atiq is often cited by papers focused on Platelet Disorders and Treatments (25 papers), Blood groups and transfusion (14 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (8 papers). Ferdows Atiq collaborates with scholars based in Netherlands, Ireland and United Kingdom. Ferdows Atiq's co-authors include Frank W.G. Leebeek, Marjon H. Cnossen, Jeroen Eikenboom, Teun van Gelder, Jorie Versmissen, Patricia M. L. A. van den Bemt, Joke de Meris, Karin Fijnvandraat, James S. O’Donnell and Johanna G. van der Bom and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and British Journal of Haematology.

In The Last Decade

Ferdows Atiq

30 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferdows Atiq Netherlands 13 247 80 77 73 55 36 397
Ravi Ranjan India 12 222 0.9× 86 1.1× 57 0.7× 37 0.5× 67 1.2× 37 378
Samantha Pasca Italy 13 291 1.2× 73 0.9× 105 1.4× 54 0.7× 136 2.5× 48 486
Inga Hegemann Switzerland 13 241 1.0× 78 1.0× 53 0.7× 65 0.9× 74 1.3× 26 510
Anna D. Petropoulou France 13 355 1.4× 82 1.0× 68 0.9× 87 1.2× 84 1.5× 25 542
Joanna Rupa‐Matysek Poland 11 171 0.7× 78 1.0× 96 1.2× 38 0.5× 131 2.4× 43 392
Karin P. M. van Galen Netherlands 18 691 2.8× 192 2.4× 97 1.3× 93 1.3× 64 1.2× 56 842
Farjah Algahtani Saudi Arabia 10 125 0.5× 113 1.4× 47 0.6× 33 0.5× 62 1.1× 43 283
Emmanuelle Jeanpierre France 12 106 0.4× 29 0.4× 111 1.4× 66 0.9× 48 0.9× 33 408
Rashid Kazmi United Kingdom 12 150 0.6× 28 0.3× 75 1.0× 29 0.4× 51 0.9× 21 333
Muhammad Ali Lak Iran 8 338 1.4× 95 1.2× 34 0.4× 72 1.0× 21 0.4× 15 447

Countries citing papers authored by Ferdows Atiq

Since Specialization
Citations

This map shows the geographic impact of Ferdows Atiq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdows Atiq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdows Atiq more than expected).

Fields of papers citing papers by Ferdows Atiq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferdows Atiq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdows Atiq. The network helps show where Ferdows Atiq may publish in the future.

Co-authorship network of co-authors of Ferdows Atiq

This figure shows the co-authorship network connecting the top 25 collaborators of Ferdows Atiq. A scholar is included among the top collaborators of Ferdows Atiq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdows Atiq. Ferdows Atiq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atiq, Ferdows, Pamela A. Christopherson, Sandra L. Haberichter, et al.. (2025). Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program. Blood Advances. 9(19). 4780–4789. 2 indexed citations
2.
Pastoor, Hester, Jeroen Eikenboom, Karin Fijnvandraat, et al.. (2025). Sexuality and bleeding in von Willebrand disease. Research and Practice in Thrombosis and Haemostasis. 9(2). 102712–102712.
3.
Lassila, Riitta, Ferdows Atiq, Caterina Casari, & Michelle Lavin. (2025). Advances in Von Willebrand Disease. Haemophilia.
4.
Chevalier, Anne, Ferdows Atiq, Jamie M. O’Sullivan, et al.. (2025). The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathy. Blood. 146(16). 1979–1990.
5.
Atiq, Ferdows, et al.. (2025). Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications. The Lancet Haematology. 12(11). e908–e917. 2 indexed citations
6.
Chion, Alain, Ferdows Atiq, Sonia Águila, et al.. (2024). The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1. Blood. 144(13). 1445–1456. 15 indexed citations
7.
Atiq, Ferdows, et al.. (2024). Variant mapping using mass spectrometry–based proteotyping as a diagnostic tool in von Willebrand disease. Journal of Thrombosis and Haemostasis. 22(7). 1894–1908. 5 indexed citations
8.
Atiq, Ferdows, Orla Rawley, Jamie M. O’Sullivan, et al.. (2024). R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI. Journal of Thrombosis and Haemostasis. 22(10). 2752–2760.
9.
Atiq, Ferdows, Karin Fijnvandraat, Karin P. M. van Galen, et al.. (2024). Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study. Journal of Thrombosis and Haemostasis. 22(12). 3460–3472. 2 indexed citations
10.
O’Donnell, James S., Ross Baker, & Ferdows Atiq. (2024). Low von Willebrand factor—unraveling an enigma wrapped in a conundrum. Journal of Thrombosis and Haemostasis. 22(12). 3383–3388. 3 indexed citations
11.
Atiq, Ferdows, Johan Boender, Waander L. van Heerde, et al.. (2022). Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease. Blood Advances. 6(18). 5317–5326. 9 indexed citations
12.
Atiq, Ferdows, Jens van de Wouw, Oana Sorop, et al.. (2021). Endothelial Dysfunction, Atherosclerosis, and Increase of von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine. Thrombosis and Haemostasis. 121(5). 676–686. 11 indexed citations
13.
Atiq, Ferdows, Nicole M. A. Blijlevens, Paul Brons, et al.. (2021). Von Willebrand disease type 2M: Correlation between genotype and phenotype. Journal of Thrombosis and Haemostasis. 20(2). 316–327. 7 indexed citations
14.
Atiq, Ferdows, Petra E. Bürgisser, Johan A. Slotman, et al.. (2021). Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms. Research and Practice in Thrombosis and Haemostasis. 5(6). e12595–e12595. 9 indexed citations
15.
Atiq, Ferdows, Marieke C. Punt, Karin P. M. van Galen, et al.. (2021). Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders. EClinicalMedicine. 32. 100726–100726. 42 indexed citations
16.
Atiq, Ferdows, et al.. (2020). Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding. Journal of Thrombosis and Haemostasis. 19(3). 719–731. 6 indexed citations
17.
Jong, Annika de, Richard Dirven, Johan Boender, et al.. (2020). Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA. Thrombosis and Haemostasis. 120(11). 1569–1579. 22 indexed citations
18.
Houwing, Maite E., Marjolein H. G. Dremmen, Ferdows Atiq, et al.. (2020). Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis. BMC Medicine. 18(1). 393–393. 35 indexed citations
19.
Atiq, Ferdows, Johan Boender, Marjon H. Cnossen, et al.. (2019). von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD. Blood Advances. 3(24). 4147–4154. 12 indexed citations
20.
Atiq, Ferdows, Annoek E. C. Broers, Louise M. Andrews, et al.. (2016). A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib. European Journal of Clinical Pharmacology. 72(6). 719–723. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravi Ranjan Breakdown of academic impact, for papers by Samantha Pasca Breakdown of academic impact, for papers by Inga Hegemann Breakdown of academic impact, for papers by Anna D. Petropoulou Breakdown of academic impact, for papers by Joanna Rupa‐Matysek Breakdown of academic impact, for papers by Karin P. M. van Galen Breakdown of academic impact, for papers by Farjah Algahtani Breakdown of academic impact, for papers by Emmanuelle Jeanpierre Breakdown of academic impact, for papers by Rashid Kazmi Breakdown of academic impact, for papers by Muhammad Ali Lak
Rankless by CCL
2026